The Gastrointestinal Endoscopic Devices Market is projected to reach USD 16.84 billion by 2032
From GlobeNewswire: 2025-07-01 09:10:00
The Gastrointestinal Endoscopic Devices Market was valued at USD 10.78 billion in 2023, expected to reach USD 16.84 billion by 2032, growing at a CAGR of 5.11%. Advancements in endoscopic procedures and rising global gastrointestinal disorders are driving this growth. Key players listed in the report include Olympus, Boston Scientific, and Medtronic.
Technological advancements have increased endoscopic instrument efficiency, integrating AI and robotics for improved accuracy. Healthcare spending and government support for early disease detection also contribute to market growth. Major players like Johnson & Johnson, Fujifilm, and Stryker offer innovative endoscopic devices for diagnostics and treatment.
Flexible gastrointestinal endoscopes dominated the market in 2023, with a share of 49.2%. Disposable endoscopes are seeing significant growth due to infection control concerns. Outpatient facilities led the market in 2023, with a 51.6% share, driven by the need for affordable and convenient healthcare. Hospitals are expected to see growth with investments in advanced endoscopic devices.
North America held 32.5% of the total market revenue in 2023, with well-established healthcare infrastructure. Asia-Pacific is forecasted for high growth due to increased healthcare spending and awareness. Recent developments include new endoscopic devices from Fujifilm and AnX Robotica, enhancing treatment precision and diagnostic accuracy.
The global prevalence of gastrointestinal disorders is rising, with colorectal cancer a leading cause of cancer-related deaths. North America and Europe are top regions for endoscopic procedures, but Asia-Pacific is expected to see significant growth. North America leads in healthcare expenditure, while Asia-Pacific countries are increasing budgets for medical modernization.
Read more at GlobeNewswire: Gastrointestinal Endoscopic Devices Market Size Set to